By Martin Bricketto ( August 13, 2015, 3:46 PM EDT) -- Merck Sharp & Dohme Corp. on Thursday won a New Jersey appellate ruling backing the toss of a failure-to-warn suit over the arthritis drug Vioxx, with the court agreeing that an expert report for the plaintiff's estate fell short in linking the drug to his heart problems....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.